@xconomy.com 3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com 4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com 4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com 4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@slashgear.com 4 years ago
Superbug tuberculosis treatment gets FDA approval as cases skyrocket
@slashgear.com 4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@slashgear.com 4 years ago
Don’t blame the measles vaccine for global outbreaks
@xconomy.com 5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com 5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@venturebeat.com 5 years ago
Zebra Medical gains FDA approval for AI-powered heart disease detection
@xconomy.com 5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@techcrunch.com 8 years ago
We Asked Rock Health Founder Halle Tecco About The Future Of Digital Medicine